全国中医药系统培训行政复议与行政诉讼

2018-05-23 栗征 中国中医

5月17~18日,国家中医药管理局政策法规与监督司在福建省福州市举办全国中医药系统行政复议与行政诉讼专题培训班。

5月17~18日,国家中医药管理局政策法规与监督司在福建省福州市举办全国中医药系统行政复议与行政诉讼专题培训班。

中医药法于去年7月1日正式施行后,相关配套政策法规陆续发布,对包括行政复议和行政诉讼应诉工作在内的中医药法治工作提出新的更高的要求。本次培训通过进一步夯实法律知识、强化法治意识、把握关键环节,不断防范系统风险,提高行政复议与行政诉讼工作能力和水平,既是中医药系统深入贯彻全面依法治国战略部署要求,全面推进依宪施政、依法行政的重要举措,也是进一步深化中医药法学习宣传贯彻,深入推进中医药“七五”普法宣传教育,落实“谁执法谁普法”的普法责任制的具体行动。

本次培训专题授课与交流研讨相结合。专题授课涵盖行政复议法、行政诉讼法、卫生行政复议与行政诉讼、中医药行政复议与行政诉讼风险防范等内容。

国家中医药管理局机关各司办、各直属单位,全国各省(区、市)中医药管理部门相关工作负责同志共100余人参加培训。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1804372, encodeId=8fe118043e2e5, content=<a href='/topic/show?id=f880e69029d' target=_blank style='color:#2F92EE;'>#系统培训#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76902, encryptionId=f880e69029d, topicName=系统培训)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Oct 18 07:41:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667054, encodeId=d33d166e054b3, content=<a href='/topic/show?id=1bbf915547d' target=_blank style='color:#2F92EE;'>#诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91554, encryptionId=1bbf915547d, topicName=诉讼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef326082418, createdName=wjcjjian, createdTime=Sun Apr 21 01:41:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322970, encodeId=a0e63229e0ec, content=谢谢.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:12 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409536, encodeId=3b5f14095364a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu May 24 23:41:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812646, encodeId=41061812646e6, content=<a href='/topic/show?id=909790080dd' target=_blank style='color:#2F92EE;'>#行政诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90080, encryptionId=909790080dd, topicName=行政诉讼)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed May 01 11:41:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318095, encodeId=c9d5318095f4, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:03:08 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1804372, encodeId=8fe118043e2e5, content=<a href='/topic/show?id=f880e69029d' target=_blank style='color:#2F92EE;'>#系统培训#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76902, encryptionId=f880e69029d, topicName=系统培训)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Oct 18 07:41:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667054, encodeId=d33d166e054b3, content=<a href='/topic/show?id=1bbf915547d' target=_blank style='color:#2F92EE;'>#诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91554, encryptionId=1bbf915547d, topicName=诉讼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef326082418, createdName=wjcjjian, createdTime=Sun Apr 21 01:41:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322970, encodeId=a0e63229e0ec, content=谢谢.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:12 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409536, encodeId=3b5f14095364a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu May 24 23:41:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812646, encodeId=41061812646e6, content=<a href='/topic/show?id=909790080dd' target=_blank style='color:#2F92EE;'>#行政诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90080, encryptionId=909790080dd, topicName=行政诉讼)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed May 01 11:41:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318095, encodeId=c9d5318095f4, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:03:08 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2019-04-21 wjcjjian
  3. [GetPortalCommentsPageByObjectIdResponse(id=1804372, encodeId=8fe118043e2e5, content=<a href='/topic/show?id=f880e69029d' target=_blank style='color:#2F92EE;'>#系统培训#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76902, encryptionId=f880e69029d, topicName=系统培训)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Oct 18 07:41:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667054, encodeId=d33d166e054b3, content=<a href='/topic/show?id=1bbf915547d' target=_blank style='color:#2F92EE;'>#诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91554, encryptionId=1bbf915547d, topicName=诉讼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef326082418, createdName=wjcjjian, createdTime=Sun Apr 21 01:41:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322970, encodeId=a0e63229e0ec, content=谢谢.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:12 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409536, encodeId=3b5f14095364a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu May 24 23:41:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812646, encodeId=41061812646e6, content=<a href='/topic/show?id=909790080dd' target=_blank style='color:#2F92EE;'>#行政诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90080, encryptionId=909790080dd, topicName=行政诉讼)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed May 01 11:41:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318095, encodeId=c9d5318095f4, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:03:08 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2018-06-10 执着追梦

    谢谢.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1804372, encodeId=8fe118043e2e5, content=<a href='/topic/show?id=f880e69029d' target=_blank style='color:#2F92EE;'>#系统培训#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76902, encryptionId=f880e69029d, topicName=系统培训)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Oct 18 07:41:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667054, encodeId=d33d166e054b3, content=<a href='/topic/show?id=1bbf915547d' target=_blank style='color:#2F92EE;'>#诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91554, encryptionId=1bbf915547d, topicName=诉讼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef326082418, createdName=wjcjjian, createdTime=Sun Apr 21 01:41:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322970, encodeId=a0e63229e0ec, content=谢谢.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:12 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409536, encodeId=3b5f14095364a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu May 24 23:41:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812646, encodeId=41061812646e6, content=<a href='/topic/show?id=909790080dd' target=_blank style='color:#2F92EE;'>#行政诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90080, encryptionId=909790080dd, topicName=行政诉讼)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed May 01 11:41:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318095, encodeId=c9d5318095f4, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:03:08 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2018-05-24 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1804372, encodeId=8fe118043e2e5, content=<a href='/topic/show?id=f880e69029d' target=_blank style='color:#2F92EE;'>#系统培训#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76902, encryptionId=f880e69029d, topicName=系统培训)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Oct 18 07:41:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667054, encodeId=d33d166e054b3, content=<a href='/topic/show?id=1bbf915547d' target=_blank style='color:#2F92EE;'>#诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91554, encryptionId=1bbf915547d, topicName=诉讼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef326082418, createdName=wjcjjian, createdTime=Sun Apr 21 01:41:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322970, encodeId=a0e63229e0ec, content=谢谢.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:12 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409536, encodeId=3b5f14095364a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu May 24 23:41:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812646, encodeId=41061812646e6, content=<a href='/topic/show?id=909790080dd' target=_blank style='color:#2F92EE;'>#行政诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90080, encryptionId=909790080dd, topicName=行政诉讼)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed May 01 11:41:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318095, encodeId=c9d5318095f4, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:03:08 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1804372, encodeId=8fe118043e2e5, content=<a href='/topic/show?id=f880e69029d' target=_blank style='color:#2F92EE;'>#系统培训#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76902, encryptionId=f880e69029d, topicName=系统培训)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Oct 18 07:41:00 CST 2018, time=2018-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667054, encodeId=d33d166e054b3, content=<a href='/topic/show?id=1bbf915547d' target=_blank style='color:#2F92EE;'>#诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91554, encryptionId=1bbf915547d, topicName=诉讼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef326082418, createdName=wjcjjian, createdTime=Sun Apr 21 01:41:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322970, encodeId=a0e63229e0ec, content=谢谢.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sun Jun 10 07:37:12 CST 2018, time=2018-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409536, encodeId=3b5f14095364a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu May 24 23:41:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812646, encodeId=41061812646e6, content=<a href='/topic/show?id=909790080dd' target=_blank style='color:#2F92EE;'>#行政诉讼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90080, encryptionId=909790080dd, topicName=行政诉讼)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed May 01 11:41:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318095, encodeId=c9d5318095f4, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 24 08:03:08 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2018-05-24 执着追梦

    学习.谢谢分享

    0

相关资讯

6位中医药人获全国五一劳动奖章

2018年庆祝“五一”国际劳动节暨“当好主人翁、建功新时代”劳动和技能竞赛推进大会4月28日在北京人民大会堂举行。全国人大常委会副委员长、中华全国总工会主席王东明出席并讲话。

国家市场总局: 全国开查医药商业贿赂!

国家市场总局:5月-10月,医药行业商业贿赂,全国查!5月17日,国家市场监督管理总局发布《关于开展反不正当竞争执法重点行动的公告〔2018年第4号〕》。▍全国范围,查医药商业贿赂这个今年4月10日挂牌的,国务院直属机构决定,自2018年5月至10月,在全国范围内开展反不正当竞争执法重点行动。此次执法行动,重点围绕网络交易、农村市场、医药、教育等行业和领域。集中整治社会关注度高、反映强烈的市

国家卫生健康委规范全国医院信息化建设

为促进和规范医院信息化建设,国家卫生健康委日前印发《全国医院信息化建设标准与规范(试行)》,明确医院信息化建设的建设内容和建设要求。

全国中医药教育管理工作会召开

2018年全国中医药教育管理工作会议在陕西西安召开。会议传达学习了习近平总书记发展中医药的新思想新论断新要求,总结了党的十八大以来中医药教育工作取得的成效,研究部署了2018年重点工作任务。

2018年全国中医药工作会召开后,来看看各地是如何贯彻落实的

2018年全国中医药工作会议召开后,各地中医药管理部门及时传达学习并贯彻落实会议精神,以坚持中西医并重、传承发展中医药事业为指导,以贯彻落实中医药法和中医药发展战略规划纲要为抓手,抢抓机遇促发展,积极部署2018年中医药工作。

全国中医药规划财务工作会召开

2018年全国中医药规划财务工作会议在辽宁省沈阳市召开。会议充分肯定了党的十八大以来规划财务工作取得的成绩,研究部署下一步重点任务。